Tissue Engineering

Can Nanocarriers Overcome Resistance in Head and Neck Cancer?
Research & Development Can Nanocarriers Overcome Resistance in Head and Neck Cancer?

Bioinformatics analyses have identified the kinase DYRK1A as a critical upstream regulator that maintains tumor growth even when standard signaling pathways are pharmacologically blocked. From 2026 to 2030, the global incidence of head and neck squamous cell carcinoma (HNSCC) is expected to grow by

What Is the Future of Keratin in Tissue Engineering?
Biotech & Bioprocessing What Is the Future of Keratin in Tissue Engineering?

The future of regenerative medicine may depend on refining extraction processes to preserve higher-molecular-weight proteins within hybrid keratin-based systems. As the medical community faces an escalating global shortage of donor organs and tissues, the search for sustainable, bioactive

New Multi-Channel Tool Advances Electrical Cell Stimulation
Biotech & Bioprocessing New Multi-Channel Tool Advances Electrical Cell Stimulation

Electronic controller modules based on Arduino firmware now allow for the simultaneous testing of multiple electrical pulse protocols within a single standard 12-well plate. This breakthrough by researchers at the Institute of Life and Health Sciences in Portugal addresses one of the most

Can Eugenol-Infused Scaffolds Revolutionize Bone Repair?
Biotech & Bioprocessing Can Eugenol-Infused Scaffolds Revolutionize Bone Repair?

By mimicking the natural bone extracellular matrix, these composite scaffolds address the physiological limitations of existing synthetic materials used in orthopedic surgery. The global healthcare landscape is currently navigating a quiet but profound crisis as bone-related injuries and

Aspen’s Parkinson’s Cell Therapy Faces the Test of Translation
Biotech & Bioprocessing Aspen’s Parkinson’s Cell Therapy Faces the Test of Translation

Aspen Neuroscience’s sasineprocel starts with cells collected from a patient’s skin and aims to rebuild a population of neurons lost in Parkinson’s disease. To advance clinical testing, the company has raised $140.6 million through an initial public offering. The program now has to answer a central

Human Amniotic Membrane Advances in Regenerative Medicine
Research & Development Human Amniotic Membrane Advances in Regenerative Medicine

Injectable amniotic membrane powder is being investigated for its disease-modifying potential in treating osteoarthritis, as it contains factors that suppress enzymes responsible for cartilage breakdown. This transition from a specialized tool in ophthalmology to a cornerstone of orthopedics and

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later